|
2024
|
G/S
|
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, A... |
|
|
G/S
|
Product development; Pharmaceutical products development; Biological development services; Resear... |
|
|
G/S
|
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention an... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer Medical information services in the field... |
|
|
G/S
|
Education services, namely, online and telephone coaching regarding the treatment of inflammatory... |
|
|
G/S
|
Medical information services in the field of endocrine and obesity |
|
|
G/S
|
Providing medical information; providing medical information in the field of Alzheimer's. |
|
|
G/S
|
Medical information services, namely providing information related to healthcare and diseases and... |
|
|
G/S
|
Downloadable software in the nature of a mobile application for providing healthcare-related info... |
|
|
G/S
|
Educational services on the topic of medical matters; arranging and conducting educational forums... |
|
|
G/S
|
Providing medical research data captured from wearable biosensors in the field of pharmaceuticals... |
|
|
G/S
|
Scientific research and development; Scientific laboratory services, namely, providing shared wet... |
|
2023
|
Invention
|
Lasofoxifene combination treatment of er+ breast cancer that has progressed on a cdk4/6 inhibitor... |
|
|
Invention
|
Medication delivery device including disposable and reusable portions.
A medication delivery dev... |
|
|
Invention
|
Medication delivery device with a sensed element.
A medication delivery device including a devic... |
|
|
Invention
|
Kcnq potentiators.
Small molecule potentiatiors to potassium channels (such as Kv7 potentiators—... |
|
|
Invention
|
Long-acting natriuretic peptides and uses thereof. The present invention relates to Atrial Natriu... |
|
|
Invention
|
Preserved gip/glp agonist compositions. A preserved composition of tirzepatide, comprising less t... |
|
|
Invention
|
Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-n-[6-(1-methyl-pipe... |
|
|
Invention
|
Compositions and methods of use of interleukin-10 in combination with immune check-point pathway ... |
|
|
Invention
|
Apparatuses for and methods of concentrating biomolecules. An apparatus is described for concentr... |
|
|
Invention
|
Wearable sensor for monitoring solid and liquid consumption. The present disclosure relates to a ... |
|
|
Invention
|
Synthesis of 6-fluoro-2-methylbenzo[d]thiazol-5-yl compounds. The present invention provides impr... |
|
|
Invention
|
Methods for producing fabs and igg bispecific antibodies.
Methods for producing Fabs and IgG bi-... |
|
|
Invention
|
Methods and systems for using causal networks to develop models for evaluating biological process... |
|
|
Invention
|
Methods of treating fatigue in ulcerative colitis. The present invention generally relates to met... |
|
|
Invention
|
Peptides for incretin synthesis. Provided are crystalline forms of peptide fragments, method of p... |
|
|
Invention
|
Gene therapy for trem2-associated diseases and disorders. Nucleic acids are described that encode... |
|
|
Invention
|
Gene therapy for trem2-associated diseases and disorders.
Nucleic acids are described that encod... |
|
|
Invention
|
Method and injection-moulding device for injection moulding of plastics parts. The invention rela... |
|
|
Invention
|
Glucocorticoid receptor agonists. The present invention provides a compound of Formula I: wherein... |
|
|
Invention
|
Oral drug delivery device with expanding arms. The present disclosure provides a drug delivery de... |
|
|
Invention
|
Anti-human lair1 antibodies.
The present disclosure relates to antibodies that bind human LAIR1 ... |
|
|
Invention
|
Anti-human lair1 antibodies. The present disclosure relates to antibodies that bind human LAIR1 (... |
|
|
Invention
|
Treatment and prevention of diseases. Methods of modulating expression and / or secretion of at l... |
|
|
Invention
|
Systems and methods for detecting state of a medication delivery device. A sensing system for det... |
|
|
Invention
|
Gip and glp-1 dual agonist compounds. The present invention relates to a pharmaceutical compositi... |
|
|
Invention
|
A gip/glp1 for use in therapy. The present invention provides a method for improving glycemic con... |
|
|
Invention
|
Cocrystalline forms of fgfr3 inhibitors.
Provided herein are cocrystalline forms of FGFR3 inhibi... |
|
|
Invention
|
Pyrazolo[1,5-a]pyridine and imidazo[1,2-a]pyridine derivatives as fgfr3 inhibitors for the treatm... |
|
|
Invention
|
Co-crystals of 4-[4-[3-chloro-4-[1-(2-pyridyl)-2-hydroxy-ethoxy]pyrazolo[1,5-a]pyridin-6-yl]-5-me... |
|
|
Invention
|
Infusion site failure detection. Systems, methods, and devices are provided for predicting a stat... |
|
|
Invention
|
Compositions for oral delivery. The present invention relates to a dosage form suitable for oral ... |
|
|
Invention
|
Pd-1 agonist antibodies and methods of treating autoimmune diseases with a pd-1 agonist antibody.... |
|
|
Invention
|
Sstr4 agonist salts.
The present invention relates to specific salts of (1S,5R)-(1α,5α,6α)-N-[1,... |
|
|
Invention
|
Transferrin receptor binding proteins and conjugates.
Provided herein are proteins comprising on... |
|
|
Invention
|
Transferrin receptor binding proteins and conjugates. Provided herein are proteins comprising one... |
|
|
Invention
|
Kras g12c inhibitor dosing regimens.
Disclosed herein are dosing regimens for the administration... |
|
|
Invention
|
Human interleukin-4 receptor alpha antibody glucocorticoid conjugates.
The present disclosure pr... |
|
|
Invention
|
Human tumor necrosis factor alpha antibody glucocorticoid conjugates.
The present disclosure pro... |
|
|
Invention
|
Variant adeno-associated virus (aav) capsid polypeptides and gene therapeutics thereof for treatm... |
|
|
Invention
|
Kras inhibitors.
The present invention provides compounds of the formula:
The present inventio... |
|
2022
|
Invention
|
Methods of treating cancer with pdgfr alpha inhibitors.
Methods for treating cancer patients wit... |
|
|
Invention
|
Self-aspirating syringe systems, cartridges, and methods.
A cartridge is configured to receive a... |
|
|
Invention
|
Methods and apparatus for incremental learning using stored features.
Computerized techniques ar... |
|
|
Invention
|
Status sensing systems for connected injection device.
Drug-delivery systems configured to gener... |
|
|
Invention
|
Tirzepatide therapeutic methods.
An embodiment of the invention relates to method for increasing... |
|
|
Invention
|
Oxyntomodulin binding molecules, and uses thereof.
Provided herein are novel N- and C-terminal o... |
|
2021
|
Invention
|
Methods of treating diabetes.
Described herein are fixed doses and dosing regimens for long-acti... |
|
|
Invention
|
Methods of treating diabetes.
Described herein are doses and dosing regimens comprising determin... |
|
2020
|
Invention
|
Medication delivery device with needle carrier.
Drug delivery devices are provided having a need... |
|
2019
|
Invention
|
Fab-based trispecific antibodies.
The present invention generally relates to Fab-based antibody-... |
